The association between estrogen receptor alpha polymorphisms and the risk of prostate cancer in Slovak population

Molecular and Cellular Biochemistry

Volumn 381, Issue 1-2, 2013, Pages 201-207

  Jurečeková, Jana ^a   Sivoňová, Monika Kmeťová ^a   Evinová, Andrea ^a   Kliment, Ján ^a   Dobrota, Dušan ^a  

^a University Hospital in Martin   (Slovakia)

Author keywords

Estrogen receptor alpha; Gene polymorphism; Gleason score; Prostate cancer; Slovak population

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CARCINOMA; SLOVAKIA;

AGED; ALLELES; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; SLOVAKIA;

EID: 84882581112     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1703-x     Document Type: Article

References (33)

1. Vrdoljak E, Wojtukiewicz MZ, Pienkowski T, Bodoky G, Ber-zinec P, Finek J, Todorović V, Borojević N, Croitoru A, South Eastern European Research Oncology Group (2011) Cancer epidemiology in Central, South and Eastern European countries. Croat Med J 52:478-487. doi:10.3325/cmj.2011.52.478
2. Hsing AW, Chokkalingam AP (2008) Prostate cancer epidemiology. Front Biosci 11:1388-1413
3. Schaid DJ (2004) The complex genetic epidemiological of prostate cancer. Hum Mol Genet 13 Spec No 1:R103-R121
4. Bosland MC (2000) The role of steroid hormones in prostate cancinogenesis. J Natl Cancer Inst Monogr 27:39-66
5. Soni A, Bansal A, Mishra AK, Batra J, Singh LC, Chakraborty A, Yadav DS, Mohanty NK, Saxena S (2012) Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population. Genet Test Mol Bio-markers 16:835-840. doi:10.1089/gtmb.2011.0322
6. Monteiro C, Sousa MV, Ribeiro R, Maurício J, Fraga A, Medeiros R (2013) Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer. Med Oncol 30:490. doi:10.1007/s12032-013-0490-2
7. Li Q, Zhu Y, He J, Wang M, Zhu M, Shi T, Qiu L, Ye D, Wei Q (2013) Steroid 5-alpha-reductase type2(SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis. Mol Biol Rep 40(5):3597-3608. doi:10.1007/s11033-012-2434-x
8. Söderström T, Wadelius M, Andersson SO, Johansson JE, Johansson S, Granath F, Rane A (2002) 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer. Pharmacogenetics. 12:307-312
9. Oh WK (2002) The evolving role of estrogen therapy in prostate cancer. Clin Prostate Cancer 1:81-89
10. Carruba G (2007) Estrogen and prostate cancer: an eclipse truth in an androgen-dominated scenario. J Cell Biochem 102:899-911
11. Ellem SJ, Risbridger GP (2009) The dual, opposing roles of estrogen in the prostate. Ann N Y Acad Sci 1155:174-186
12. Ho SM, Leung YK, Chung I (2006) Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer. Ann N Y Acad Sci 1089:177-193
13. Royuela M, de Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Arenas MI, Paniagua R (2001) Estrogen receptors a and ß in the normal, hyperplastic and carcinomatous human prostate. J Endocrinol 168:447-454
14. Vanacker JM, Pettersson K, Gustafsson JA, Laudet V (1999) Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) a, but not by ERb. EMBO J 18:4270-4279
15. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, Gustafsson JA, Cunha G (2001) Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol 229:432-442
16. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, Gustafsson JA, Cunha G, Wong YZ (2001) Evidence that epithelial and mesenchymal estrogen receptor- A mediates effects of estrogen on prostatic epithelium. Dev Biol 229:432-442
17. McPherson S, Wang H, Jones M, Pedersen J, Iismaa T, Wreford N, Simpson E, Risbridger G (2001) Elevated androgens and prolactin in aromatase deficient (ArKO) mice cause enlargement but not malignancy of the prostate gland. Endocrinol 142:2458-2467
18. McPherson S, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbrider GP (2007) Essential role for estrogen receptor b in stromal-epithelial regulation of prostatic hyperplasia. Endocrinol 148:54-566
19. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H (1996) Association of bone mineral density with polymorphism of estrogen receptor gene. J Bone Miner Res 11:306-311
20. Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S (2012) Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men. Mol Carcinog 51(Suppl 1): E104-E117
21. Herrington DM, Howard TD, Brosnihan KB, McDonnel DP, Li X, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Meyers DA, Bleecker ER (2002) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105:1879-1882
22. Beleza-Meireles A, Omrani D, Kockum I, Frisen L, Lagerstedt K, Nordenskjold A (2006) Polymorphisms of estrogen receptor beta gene are associated with hypospadias. J Endocrinol Invest 29:5-10
23. Modungo F, Weissfeld JL, Trump DL, Zmuda JM, Shea P et al (2001) Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res 7:3092-3096
24. Fukatsu T, Hirokawa Y, Araki T, Hioki T, Murata T (2004) Genetic polymorphism of hormone-related genes and prostate cancer risk in the Japanese population. Anticancer Res 24:2431-2437
25. Hernandez J, Balic I, Johnson-Pais TL, Higgins BA, Torkko KC, Thompson IM, Leach RJ (2006) Association between an estrogen receptor alpha gene polymorphism and the risk of prostate cancer in black men. J Urol 175:523-527
26. Balistreri CR, Caruso C, Carruba G, Miceli V, Candore G (2011) Genotyping of sex hormone-related pathways in benign and malignant human prostate tissue: data of a preliminary study. J Integr Biol 15:369-374
27. Sissung TM, Danesi R, Kirkland T, Baum CE, Ockers SB, Stein EV, Venzon D, Price DK, Figg WD (2011) Estrogen receptor a and aromatase polymorphisms affect risk, prognosis, and therapeutic outcome in men with castration-resistant prostate cancer treated with docetaxel-based therapy. J Clin Endocrinol Metab 96:E368-E372
28. Gupta L, Thakur H, Sobti RC, Seth A, Singh SK (2010) Role of genetic polymorphism of estrogen receptor- A gene and the risk of prostate cancer in north Indian population. Mol Cell Biochem 335:255-261
29. Low YL, Taylor JI, Grace PB, Mulligan AA, Welch AA, Scollen S, Dunning AM, Luben RN, Khaw KT, Day NE, Wareham NJ, Bingham SA (2006) Phytoestrogen exposure, polymorphism in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. Nutr Cancer 56:31-39
30. Sasaki M, Tanaka Y, Sakuragi N, Daiya R (2003) Eur J Clin Pharmacol 59:389-393
31. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R (2003) Polymorphisms of estrogen receptor alpha in prostate cancer. Mol Carcinog 37:202-208
32. Beuten J, Gelfond JAL, Franke JL et al (2009) Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 18:1869-1880
33. Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B, Nishii M, Ohtake N, Nakata S, Ito K, Yamanaka H (2003) Genetic polymorphisms of estrogen receptor alpha, CYP19, cat-echol-O-methyltransferase are associated with familial prostate cancer risk in a Japanese population. Cancer 98:1411-1416